Preclinical studies have demonstrated that even pico- or nanomolar concentrations of HDP-101 are extremely cytotoxic to BCMA-positive myeloma cells and non-proliferating primary MM cells isolated from RRMM irrespective of BCMA level of expression. This evidence concerns the gene TNFRSF17 and plasma cell myeloma.